Neurocareai, Inc. (Dba Savelife.Ai)

Neurocareai, Inc. (Dba Savelife.Ai) has 1 AI-enabled medical device on the FDA list. The first decision was on May 4, 2026 and the most recent on May 4, 2026 (MammoSightAI). Its most common review panel is Radiology (1 device).